These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25115191)

  • 1. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
    Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
    Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
    Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
    OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
    Carlsson A; Persson O; Ingvarsson J; Widegren B; Salford L; Borrebaeck CA; Wingren C
    Proteomics Clin Appl; 2010 Jul; 4(6-7):591-602. PubMed ID: 21137077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome analysis of Glioblastoma cell line--HNGC-2.
    Gupta MK; Polisetty RV; Ramamoorthy K; Tiwary S; Kaur N; Uppin MS; Shiras A; Sirdeshmukh R
    Mol Biosyst; 2013 Jun; 9(6):1390-400. PubMed ID: 23483059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.
    Schuhmann MU; Zucht HD; Nassimi R; Heine G; Schneekloth CG; Stuerenburg HJ; Selle H
    Eur J Surg Oncol; 2010 Feb; 36(2):201-7. PubMed ID: 19674866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model.
    Greco F; Anastasi F; Pardini LF; Dilillo M; Vannini E; Baroncelli L; Caleo M; McDonnell LA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel human glioblastoma-specific transcripts by serial analysis of gene expression data mining.
    Su Y; Xiong J; Bing Z; Zeng X; Zhang Y; Fu X; Peng X
    Cancer Biomark; 2013; 13(5):367-75. PubMed ID: 24440977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of glioblastoma multiforme.
    Nicolaidis S
    Metabolism; 2015 Mar; 64(3 Suppl 1):S22-7. PubMed ID: 25468141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.
    Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma biomarkers from bench to bedside: advances and challenges.
    Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
    Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.
    Miyauchi E; Furuta T; Ohtsuki S; Tachikawa M; Uchida Y; Sabit H; Obuchi W; Baba T; Watanabe M; Terasaki T; Nakada M
    PLoS One; 2018; 13(3):e0193799. PubMed ID: 29513714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.
    Heroux MS; Chesnik MA; Halligan BD; Al-Gizawiy M; Connelly JM; Mueller WM; Rand SD; Cochran EJ; LaViolette PS; Malkin MG; Schmainda KM; Mirza SP
    Physiol Genomics; 2014 Jul; 46(13):467-81. PubMed ID: 24803679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
    Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating biomarker panels for targeted therapy in brain tumors.
    Tanase C; Albulescu R; Codrici E; Popescu ID; Mihai S; Enciu AM; Cruceru ML; Popa AC; Neagu AI; Necula LG; Mambet C; Neagu M
    Future Oncol; 2015; 11(3):511-24. PubMed ID: 25241806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.